Genomed Spólka Akcyjna

zł 37.00As of Sun 8 Nov 2026, 12:00 UTC
WSE:GENHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR 8.11%
Div yield 4.05%
ROE —
Diagnostics & Research
Beta (5Y) 0.01
PE TTM 13.94
TSR TTM 41.37%
Mkt cap zł 48.89M
ROIC 51.14%
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 45
22.08%
(27.51%)
Hold 11|2|9|6|2
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.49
0.49
0.53
0.57
28.60%
31.68%
28.37%
28.16%
Revenuezł M
3.781
3.686
3.766
3.670
(1.46%)
(2.79%)
0.21%
(4.97%)
Peers (US$12.35M)
Cap (US$)
PE
75.84M
—
9.191M
44.99x
12.27M
—
Capital
TTM
5Y
10Y
Leveragex
0.111
0.453
0.420
EBIT/Intx
2.631
1.191
1.108
Own earn%
(45.11)
6.36
(0.08)
Sh yield%
23.52
37.24
37.32
Owners
Insiders/Inst%
10.69
42.64
Short interest%
1.87
SBC / revenue%
3.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
22–25
$1 testx
0.0
Incr. ROIC%
6